Target intelligence / Profile preview

Eukaryotic translation initiation factor 4A1 pseudogene 10 (EIF4A1P10)

Target: EIF4A1P10
Molecular classification: Pseudogene, Processed pseudogene (general classification—no subtype information available for EIF4A1P10 specifically, but most EIF4A1 pseudogenes are processed)

Overview

Eukaryotic translation initiation factor 4A1 pseudogene 10 (EIF4A1P10) is a human genomic pseudogene derived from eukaryotic translation initiation factor 4A1, an RNA helicase involved in the initiation of translation in eukaryotic cells[1][5][4]. Pseudogenes are generally non-coding DNA sequences arising by duplication or retrotransposition from functional genes; they accumulate mutations and usually do not encode active proteins[6]. Some pseudogenes can have regulatory roles at the RNA level—such as serving as sources of endogenous siRNAs, acting as miRNA sponges, or participating in competing endogenous RNA (ceRNA) networks—but there is no specific evidence to support that EIF4A1P10 acts in this way[6][8]. EIF4A1P10 is not involved in characterized biological processes or disease mechanisms, is not a drug target, nor is it used as a biomarker[1][4][5].

Other names: EIF4A1P10Eukaryotic translation initiation factor 4A1 pseudogene 10

Mechanism of action

Null (No drug mechanisms of action are relevant)

Biological functions

Null (Specific biological function not attributed; in general, some pseudogenes can regulate cognate gene expression, but this is not confirmed for EIF4A1P10)

Disease associations

Null (No disease association reported for EIF4A1P10; however, in general, some pseudogenes can be aberrantly expressed in cancer, but EIF4A1P10 has not been specifically implicated)

Safety considerations

Null (No safety concerns or therapeutic challenges noted, as this is not a therapeutic target)

Interacting drugs

Null (No known drugs interact with this pseudogene)

Biomarkers

Null (Not described as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4A1 pseudogene 10 (EIF4A1P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 10 (EIF4A1P10).

Explore the full profile